Imatinib Tablets
Product Name: Imatinib Tablets
Common Name: Imatinib Mesylate
Strength: Imatinib Mesylate: 400 mg per tablet
Description:
Imatinib Tablets is a tyrosine kinase inhibitor used primarily in the treatment of certain types of cancer. Imatinib works by inhibiting the BCR-ABL tyrosine kinase, which is produced by the Philadelphia chromosome abnormality in chronic myeloid leukemia (CML) and some other cancers. This inhibition prevents cancer cells from proliferating and promotes apoptosis (cell death).
Indications and Usage:
Imatinib Tablets is indicated for the treatment of newly diagnosed adult and pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. And also treatment of adult patients with Ph+ CML in blast crisis, accelerated phase, or in the chronic phase after failure of interferon-alpha therapy. Further it is used in the treatment of adult patients with relapsed or refractory Ph+ acute lymphoblastic leukemia (Ph+ ALL). Treatment of myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with platelet-derived growth factor receptor (PDGFR) gene re-arrangements. Treatment of advanced hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) with FIP1L1-PDGFRα fusion kinase. Treatment of dermatofibrosarcoma protuberans (DFSP) that is unresectable, recurrent, and/or metastatic. Treatment of gastrointestinal stromal tumors (GIST) that are unresectable and/or metastatic.
Features:
Pack Size: Imatinib Tablets has 1×10 tablets in each pack. It can be customise as per buyer’s specification.
Minimum Order Quantity: 3500 Packs
Certification: WHO-GMP Certified Facility.
